- Assembly Biosciences Reports Fourth Quarter and Year End 2023 Financial Results and Recent Highlights
- Assembly Biosciences Announces Effective Date of Reverse Stock Split
- Assembly Biosciences Provides Anticipated Development Milestones for 2024
- Assembly Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- Assembly Biosciences Presents New Data Highlighting Viral Hepatitis Portfolio at AASLD The Liver Meeting®
- Assembly Biosciences Reports Third Quarter 2023 Financial Results and Recent Updates
- Assembly Biosciences Names Anuj Gaggar, MD, PhD, as Chief Medical Officer
- Assembly Biosciences to Present New Data at AASLD The Liver Meeting®
- Assembly Biosciences Nominates Development Candidate ABI-6250, an Orally Bioavailable HDV Entry Inhibitor
- Assembly Biosciences to Highlight Pipeline Progress in HBV and HDV at the 2023 International HBV Meeting
More ▼
Key statistics
On Wednesday, Assembly Biosciences Inc (ASMB:NSQ) closed at 13.48, 75.25% above the 52 week low of 7.69 set on Nov 22, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 13.40 |
---|---|
High | 13.48 |
Low | 13.05 |
Bid | 12.90 |
Offer | 14.20 |
Previous close | 13.27 |
Average volume | 14.93k |
---|---|
Shares outstanding | 5.48m |
Free float | 3.67m |
P/E (TTM) | -- |
Market cap | 72.76m USD |
EPS (TTM) | -14.02 USD |
Data delayed at least 15 minutes, as of Apr 24 2024 19:09 BST.
More ▼